A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women.

Saved in:
Bibliographic Details
Title: A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women.
Authors: Cigler T; Weill Cornell Medical College, New York, NY, USA., Richardson H, Yaffe MJ, Fabian CJ, Johnston D, Ingle JN, Nassif E, Brunner RL, Wood ME, Pater JL, Hu H, Qi S, Tu D, Goss PE
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2011 Apr; Vol. 126 (2), pp. 453-61. Date of Electronic Publication: 2011 Jan 09.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 21221773
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cigler+T%22">Cigler T</searchLink>; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+H%22">Richardson H</searchLink><br /><searchLink fieldCode="AU" term="%22Yaffe+MJ%22">Yaffe MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Fabian+CJ%22">Fabian CJ</searchLink><br /><searchLink fieldCode="AU" term="%22Johnston+D%22">Johnston D</searchLink><br /><searchLink fieldCode="AU" term="%22Ingle+JN%22">Ingle JN</searchLink><br /><searchLink fieldCode="AU" term="%22Nassif+E%22">Nassif E</searchLink><br /><searchLink fieldCode="AU" term="%22Brunner+RL%22">Brunner RL</searchLink><br /><searchLink fieldCode="AU" term="%22Wood+ME%22">Wood ME</searchLink><br /><searchLink fieldCode="AU" term="%22Pater+JL%22">Pater JL</searchLink><br /><searchLink fieldCode="AU" term="%22Hu+H%22">Hu H</searchLink><br /><searchLink fieldCode="AU" term="%22Qi+S%22">Qi S</searchLink><br /><searchLink fieldCode="AU" term="%22Tu+D%22">Tu D</searchLink><br /><searchLink fieldCode="AU" term="%22Goss+PE%22">Goss PE</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2011 Apr; Vol. 126 (2), pp. 453-61. <i>Date of Electronic Publication: </i>2011 Jan 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21221773
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-010-1322-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 453
    Titles:
      – TitleFull: A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cigler T
      – PersonEntity:
          Name:
            NameFull: Richardson H
      – PersonEntity:
          Name:
            NameFull: Yaffe MJ
      – PersonEntity:
          Name:
            NameFull: Fabian CJ
      – PersonEntity:
          Name:
            NameFull: Johnston D
      – PersonEntity:
          Name:
            NameFull: Ingle JN
      – PersonEntity:
          Name:
            NameFull: Nassif E
      – PersonEntity:
          Name:
            NameFull: Brunner RL
      – PersonEntity:
          Name:
            NameFull: Wood ME
      – PersonEntity:
          Name:
            NameFull: Pater JL
      – PersonEntity:
          Name:
            NameFull: Hu H
      – PersonEntity:
          Name:
            NameFull: Qi S
      – PersonEntity:
          Name:
            NameFull: Tu D
      – PersonEntity:
          Name:
            NameFull: Goss PE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2011 Apr
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 126
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1